Cargando…
Genome-wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential
Genome-wide DNA hypomethylation is the most common molecular feature in human cancers associated with chromosomal instability (CIN), which is involved in the mechanisms that regulate pancreatic cancer (PC) metastasis. It was investigated whether genome-wide DNA hypomethylation affects the phenotype...
Autores principales: | Endo, Yuhei, Suzuki, Koichi, Kimura, Yasuaki, Tamaki, Sawako, Aizawa, Hidetoshi, Abe, Iku, Watanabe, Fumiaki, Kato, Takaharu, Saito, Masaaki, Futsuhara, Kazushige, Noda, Hiroshi, Konishi, Fumio, Rikiyama, Toshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015190/ https://www.ncbi.nlm.nih.gov/pubmed/35419613 http://dx.doi.org/10.3892/ijo.2022.5351 |
Ejemplares similares
-
Enhancement of DNA hypomethylation alterations by gastric and bile acids promotes chromosomal instability in Barrett’s epithelial cell line
por: Abe, Iku, et al.
Publicado: (2022) -
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
por: Watanabe, Fumiaki, et al.
Publicado: (2019) -
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients
por: Watanabe, Fumiaki, et al.
Publicado: (2021) -
Prophylactic use of pegfilgrastim enables the management of severe neutropenia without dose delays in patients with metastatic colorectal cancer treated with TAS-102 plus bevacizumab
por: Tamaki, Sawako, et al.
Publicado: (2022) -
Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
por: Fukui, Taro, et al.
Publicado: (2019)